The conflict between treatment optimization and registration of radiopharmaceuticals with fixed activity posology in oncological nuclear medicine therapy
- 24 May 2017
- journal article
- editorial
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 44 (11) , 1783-1786
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- A multicentre comparison of quantitative 90Y PET/CT for dosimetric purposes after radioembolization with resin microspheresEuropean Journal of Nuclear Medicine and Molecular Imaging, 2015
- Radioembolization of Hepatic Lesions from a Radiobiology and Dosimetric PerspectiveFrontiers in Oncology, 2014
- 99mTc-MAA–Based Dosimetry for Liver Cancer Treated Using 90Y-Loaded Microspheres: Known Proof of EffectivenessJournal of Nuclear Medicine, 2014
- Holmium-166 radioembolisation in patients with unresectable, chemorefractory liver metastases (HEPAR trial): a phase 1, dose-escalation studyThe Lancet Oncology, 2012
- Pre-therapeutic blood dosimetry in patients with differentiated thyroid carcinoma using 124-iodine: predicted blood doses correlate with changes in blood cell counts after radioiodine therapy and depend on modes of TSH stimulation and number of preceding radioiodine therapiesAnnals of Nuclear Medicine, 2012
- Efficacy of Dosimetric Versus Empiric Prescribed Activity of 131I for Therapy of Differentiated Thyroid CancerThe Journal of Clinical Endocrinology & Metabolism, 2011
- Dosimetry-guided high-activity 131I therapy in patients with advanced differentiated thyroid carcinoma: initial experienceEuropean Journal of Nuclear Medicine and Molecular Imaging, 2009
- Maximal safe dose of I-131 after failure of standard fixed dose therapy in patients with differentiated thyroid carcinomaAnnals of Nuclear Medicine, 2008
- Dosimetry for Fractionated 131 I-mIBG Therapies in Patients with Primary Resistant High-Risk Neuroblastoma: Preliminary ResultsCancer Biotherapy and Radiopharmaceuticals, 2007
- The Effect of131I Therapy on Survival of Patients with Metastatic Papillary or Follicular Thyroid CarcinomaThe Journal of Clinical Endocrinology & Metabolism, 1973